Comparison of oral glucose tolerance test (OGTT) 100 g with OGTT 75 g for evaluation of acromegalic patients and the impact of gender on test reproducibility

Clinical Endocrinology

Volumn 75, Issue 5, 2011, Pages 685-691

  Arafat, A M ^a   Muller L ^b   Mohlig M ^a   Mayr, B ^b   Kremenevskaya, N ^b   Pfeiffer, A F H ^a   Buchfelder, M ^b   Schofl C ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; INSULIN;

ACROMEGALY; ADULT; ARTICLE; FEMALE; FOLLICULAR PHASE; GENDER; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; REPRODUCIBILITY; SEX DIFFERENCE;

ACROMEGALY; ADULT; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SEX FACTORS;

EID: 80054775529     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04108.x     Document Type: Article

References (34)

1. Freda, P.U., (2003) Current concepts in the biochemical assessment of the patient with acromegaly. Growth Hormone & IGF Research, 13, 171-184. (Pubitemid 36980706)
2. Giustina, A., Chanson, P., Bronstein, M.D., et al. (2010) A consensus on criteria for cure of acromegaly. Journal of Clinical Endocrinology and Metabolism, 95, 3141-3148.
3. Earll, J.M., Sparks, L.L., &, Forsham, P.H., (1967) Glucose suppression of serum growth hormone in the diagnosis of acromegaly. JAMA, 201, 628-630.
4. Hattori, N., Shimatsu, A., Kato, Y., et al. (1990) Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly. Journal of Clinical Endocrinology and Metabolism, 70, 771-776.
5. Holdaway, I.M., Rajasoorya, R.C., &, Gamble, G.D., (2004) Factors influencing mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 667-674. (Pubitemid 38269875)
6. Holdaway, I.M., Bolland, M.J., &, Gamble, G.D., (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. European Journal of Endocrinology, 159, 89-95.
7. Higham, C.E., &, Trainer, P.J., (2008) Growth hormone excess and the development of growth hormone receptor antagonists. Experimental Physiology, 93, 1157-1169.
8. Freda, P.U., Nuruzzaman, A.T., Reyes, C.M., et al. (2004) Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. Journal of Clinical Endocrinology and Metabolism, 89, 495-500. (Pubitemid 38269847)
9. Ronchi, C.L., Varca, V., Giavoli, C., et al. (2005) Long-term evaluation of postoperative acromegalic patients in remission with previous and newly proposed criteria. Journal of Clinical Endocrinology and Metabolism, 90, 1377-1382. (Pubitemid 40463992)
10. Berg, C., Petersenn, S., Lahner, H., et al. (2010) Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control. Journal of Clinical Endocrinology and Metabolism, 95, 3648-3656.
11. Rosario, P.W., &, Furtado, M.S., (2008) Growth hormone after oral glucose overload: revision of reference values in normal subjects. Arquivos Brasileiros de Endocrinologia e Metabologia, 52, 1139-1144.
12. Chapman, I.M., Hartman, M.L., Straume, M., et al. (1994) Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. Journal of Clinical Endocrinology and Metabolism, 78, 1312-1319. (Pubitemid 24180997)
13. Freda, P.U., Landman, R.E., Sundeen, R.E., et al. (2001) Gender and age in the biochemical assessment of cure of acromegaly. Pituitary, 4, 163-171. (Pubitemid 34679332)
14. Costa, A.C., Rossi, A., Martinelli, C.E. Jr, et al. (2002) Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure? Journal of Clinical Endocrinology and Metabolism, 87, 3142-3147. (Pubitemid 34816356)
15. Arafat, A.M., Weickert, M.O., Frystyk, J., et al. (2009) The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity. Journal of Clinical Endocrinology and Metabolism, 94, 5093-5101.
16. Bidlingmaier, M., &, Freda, P.U., (2010) Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences. Growth Hormone & IGF Research, 20, 19-25.
17. Giustina, A., Barkan, A., Casanueva, F.F., et al. (2000) Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism, 85, 526-529. (Pubitemid 32273628)
18. Arafat, A.M., Möhlig, M., Weickert, M.O., et al. (2008) Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. Journal of Clinical Endocrinology and Metabolism, 93, 1254-1262. (Pubitemid 351519718)
19. Freda, P.U., (2009) Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clinical Endocrinology, 71, 166-170.
20. Alexopoulou, O., Bex, M., Abs, R., et al. (2008) Divergence between growth hormone and insulin-like growth factor-i concentrations in the follow-up of acromegaly. Journal of Clinical Endocrinology and Metabolism, 93, 1324-1330. (Pubitemid 351519728)
21. Carmichael, J.D., Bonert, V.S., Mirocha, J.M., et al. (2009) The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 94, 523-527.
22. Alberti, K.G., &, Zimmet, P.Z., (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15, 539-553. (Pubitemid 28319935)
23. World Health Organization. (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation.
24. Rosario, P.W., (2010) Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population. Pituitary, [Epub ahead of print]
25. Rajasoorya, C., Holdaway, I.M., Wrightson, P., et al. (1994) Determinants of clinical outcome and survival in acromegaly. Clinical Endocrinology, 41, 95-102. (Pubitemid 24232533)
26. Holdaway, I.M., Rajasoorya, C.R., Gamble, G.D., et al. (2003) Long-term treatment outcome in acromegaly. Growth Hormone & IGF Research, 13, 185-192. (Pubitemid 36980707)
27. Meinhardt, U.J., &, Ho, K.K., (2007) Regulation of growth hormone action by gonadal steroids. Endocrinology and Metabolism Clinics of North America, 36, 57-73. (Pubitemid 46321642)
28. Meinhardt, U.J., &, Ho, K.K., (2006) Modulation of growth hormone action by sex steroids. Clinical Endocrinology, 65, 413-422. (Pubitemid 44414262)
29. Weissberger, A.J., Ho, K.K., &, Lazarus, L., (1991) Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 72, 374-381. (Pubitemid 21921702)
30. Grynberg, M., Salenave, S., Young, J., et al. (2010) Female gonadal function before and after treatment of acromegaly. Journal of Clinical Endocrinology and Metabolism, 95, 4518-4525.
31. Kaltsas, G.A., Mukherjee, J.J., Jenkins, P.J., et al. (1999) Menstrual irregularity in women with acromegaly. Journal of Clinical Endocrinology and Metabolism, 84, 2731-2735. (Pubitemid 30642002)
32. Katznelson, L., Kleinberg, D., Vance, M.L., et al. (2001) Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study. Clinical Endocrinology, 54, 183-188. (Pubitemid 32193519)
33. Petersenn, S., Buchfelder, M., Gerbert, B., et al. (2009) Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register. Clinical Endocrinology, 71, 400-405.
34. Colao, A., Amato, G., Pedroncelli, A.M., et al. (2002) Gender- and age-related differences in the endocrine parameters of acromegaly. Journal of Endocrinological Investigation, 25, 532-538. (Pubitemid 34661842)